$1.73
-0.10 (-5.46%)
Pharmacyclics, Inc. (PCYC)
CAPS Rating:
A pharmaceutical company focused on the development of products that improve existing therapeutic approaches to cancer and other diseases.
A pharmaceutical company focused on the development of products that improve existing therapeutic approaches to cancer and other diseases.